Description

Peramivir is a potent and selective neuraminidase inhibitor specifically designed for the treatment of influenza virus infections. Its primary value lies in its efficacy against both influenza A and B strains, offering a critical therapeutic option in antiviral treatment regimens. This active pharmaceutical ingredient (API) is essential for pharmaceutical manufacturers developing injectable antiviral medications, particularly for patients requiring hospital-administered care.

Application

• Antiviral Drug Manufacturing: Primary use as the active pharmaceutical ingredient (API) in the formulation of injectable antiviral medications.
• Hospital Treatment Formulations: Specifically used in drugs indicated for the treatment of acute, uncomplicated influenza in patients who have been symptomatic for no more than two days.
• Parenteral Solution Development: Key component in the development of sterile, single-dose intravenous (IV) infusion solutions.
• Influenza Pandemic Preparedness: Serves as a strategic component in national and institutional stockpiles of antiviral agents for pandemic influenza response.
• Clinical Research & Development: Used as a reference standard and building block in ongoing virology research and the development of next-generation neuraminidase inhibitors.

Basic Information

Product Name	Peramivir
CAS No.	229614-55-5
Molecular Formula	C15H28N4O4
Molecular Weight	328.41 g/mol
Synonyms	Peramivir Anhydrous; (1S,2S,3R,4R)-3-[(1S)-1-Acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid; BCX-1812; RWJ-270201; Rapiacta; Alpivab; Peramivirum; Peramivir Trihydrate (hydrated form)
EINECS	Contact for details

Quality Control

Our Peramivir is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets stringent specifications for pharmaceutical use, including identity, purity, and impurity profiles. Certificates of Analysis (COA) are provided, detailing compliance with relevant pharmacopeial standards (e.g., USP, EP) and in-house specifications. We are committed to supply chain transparency and regulatory support for our global partners.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption. For long-term storage, consider desiccants or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms
Identification (HPLC)	Conforms
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Individual impurity ≤ 0.5%; Total impurities ≤ 1.5%
Microbial Enumeration	Meets Ph. Eur. 2.6.12 / USP <61>

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.